Sam Chun Dang Pharm. Co., Ltd

₩170,100As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:000250Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 32.96%
Div yield 0.03%
ROE 6.84%
Medical (Pharmaceuticals)
Beta (5Y) 1.32
PE TTM 223.2
TSR TTM (27.29%)
Mkt cap ₩3.982T
ROIC 4.45%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩201,219
18.29%
(23.74%)
Hold 6|12|2|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
2,275
2,327
2,379
2,521
16.36%
7.96%
12.20%
13.45%
Revenue₩B
511.4
513.0
514.8
508.7
18.27%
13.34%
8.07%
5.41%
Peers (US$2.936B)
Cap (US$)
PE
1.796B
14.03x
1.117B
19.92x
2.925B
85.29x
Capital
TTM
5Y
10Y
Leveragex
0.332
(0.397)
(0.275)
EBIT/Intx
2.042
0.156
0.162
Own earn%
189.00
(29.48)
(27.32)
Sh yield%
35.93
23.62
18.14
Owners
Insiders/Inst%
5.38
70.42
Short interest%
2.06
SBC / revenue%
5.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
18–25
$1 testx
—
Incr. ROIC%
13